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Mouse C3H 1OT1/2 cells and the established rat embryo fibroblast cell line REF-52 are two cell lines widely
used in studies of viral transformation. Studies have shown that transformation of 10T1/2 cells requires only
the amino-terminal 121 amino acids of simian virus 40 (SV40) large T antigen, while transformation of REF-52
cells requires considerably more of large T antigen, extending from near the N terminus to beyond residue 600.
The ability of a large set of linker insertion, small deletion, and point mutants of SV40 T antigen to transform
these two cell lines and to bind p105Rb was determined. Transformation of 1OT1/2 cells was greatly reduced by
mutations within the first exon of the gene for large T antigen but was only modestly affected by mutations
affecting the p105Rb binding site or the p53 binding region. All mutants defective for transformation of 1OT1/2
cells were also defective for transformation of REF-52 cells. In addition, mutants whose T antigens had
alterations in the Rb binding site showed a substantial reduction in transformation of REF-52 cells, and the
degree of this reduction could be correlated with the ability of the mutant T antigens to bind p105Rb. There was
a tight correlation between the ability of mutants to transform REF-52 cells and the ability of their T antigens
to bind p53. These results demonstrate that multiple regions of large T antigen are required for full
transformation by SV40.
The 5,243-bp genome of simian virus 40 (SV40) encodes
two proteins produced early after infection, the 708-amino-
acid large T antigen and the 174-amino-acid small t antigen,
as well as three capsid proteins and an additional late
protein, the agnoprotein, involved in capsid assembly. The
large T antigen is a multifunctional nuclear phosphoprotein
which has been shown to play central roles both in the lytic
infection of monkey cells and in the abortive and transform-
ing infections of rodent cells.
Enzymatically, T antigen possesses ATPase activity,
DNA and RNA helicase activities, and both specific and
nonspecific DNA-binding activities (for reviews, see refer-
ences 4 and 45). T antigen is also a transcriptional activator
(5, 24). One of the targets for this activation is the SV40 late
promoter. T antigen is also able to activate a variety of other
viral and cellular promoters, but the biological significance
of these activations is unclear (1, 47).
Infection of primary rodent embryo fibroblasts with SV40
leads to their immortalization and transformation (for a
review, see reference 50). Large T antigen acting alone is
sufficient for both immortalization and transformation,
though small t antigen may assist large T antigen in trans-
forming under conditions in which levels of large T antigen
are limiting, and under other conditions as well (3). Neither
the DNA-binding, ATPase, nor helicase activities of large T
antigen appear to be required for immortalization and trans-
formation (9, 38, 39, 56). Furthermore, the ability of large T
antigen to transactivate the SV40 late promoter can be
separated genetically from its ability to immortalize and
transform (68). It remains possible, however, that mutants
defective for transactivation of the SV40 late promoter retain
the ability to activate various cellular promoters and that
* Corresponding author.
these activations are of fundamental importance for immor-
talization, transformation, or both.
Of potentially greater importance for transformation is the
ability of T antigen to form complexes with at least two
cellular tumor suppressor gene products, p105Rb (10, 35) and
p53. The p105Rb protein is the product of the retinoblastoma
susceptibility gene, and loss or inactivation of both alleles of
this gene is associated with retinoblastomas, osteosarcomas,
and additional malignancies. The p53 gene appears to be
altered or absent in a large fraction of human tumors (for a
review, see reference 18). Unlike the Rb gene, both copies of
which must be mutated or deleted for alterations in cellular
growth to occur, mutation of a single allele of the p53 gene is
sufficient to cause substantial alterations in cellular growth
control, possibly due to the sequestration of wild-type p53 in
complexes containing both wild-type and mutant p53 poly-
peptides. It is also possible that some mutant alleles of the
p53 gene acquire additional properties that further potentiate
its ability to alter cellular growth control. T antigen is known
to associate with other cellular proteins, including DNA
polymerase a as well as the cellular heat shock cognate
proteins hsc72/73, but there is no evidence suggesting that
these latter interactions are relevant to growth control.
Formation of a complex between T antigen and p105Rb
requires sequences between amino acids 105 and 114 of T
antigen. The region of T antigen involved in forming com-
plexes with p53 extends over a much larger portion of the
protein and appears to involve multiple regions between
amino acids 347 and 626 (68). T antigen also binds to a
107K/120K cellular protein through the same sequences as it
binds p105Rb. There may be still additional cellular proteins
which form complexes with large T antigen.
The transforming proteins of DNA tumor viruses have
been studied for many years as model systems for under-
standing oncogenesis. The ElA region of human adenovi-
ruses encode two proteins, of 289 and 243 amino acids.
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These proteins share with large T antigen the ability to alter
cellular growth control. ElA proteins can immortalize pri-
mary rodent cells, and by cooperating with E1B proteins or
with other oncogene proteins, such as activated ras gene
products, they can bring about the full transformation of
primary cells (48). ElA proteins can also activate and
repress viral and cellular gene expression (16, 29, 30, 32, 51).
The regions of ElA responsible for the immortalization and
ras cooperation functions have been mapped, are contained
in both the 289- and 243-amino-acid ElA gene products, and
are conserved among different adenovirus serotypes (60).
These regions share sequence homologies with SV40 large T
antigen as well as with the E7 protein, a transforming protein
of human papillomaviruses (13). ElA, E7, and large T
antigen all bind to p105Rb (10, 13, 43, 59). Adenovirus ElA
proteins also bind another cellular protein, p300, through
sequences located near the amino terminus of the ElA
proteins (61).
The 55K EBB proteins of some serotypes of human
adenoviruses (serotypes 2 and 5 but not serotype 12) form
complexes with p53, but the region of p53 required for
complex formation with E1B proteins is different from the
region important for forming complexes with SV40 large T
antigen. The ability of ElA to cooperate with ras or E1B to
transform primary rodent fibroblasts requires that ElA be
able to bind both p300 and plo5Rb (61, 63). It is not known
whether either SV40 large T antigen or the papillomavirus
E7 protein binds to p300.
Mouse 1OT1/2 and rat REF-52 cells are two established
rodent cell lines. REF-52 cells grow relatively slowly and
morphologically resemble primary cells. 1OT1/2 cells appear
more transformed and may be closer genetically to a fully
transformed state. The amino-terminal 121 residues of T
antigen are sufficient to transform 1OT1/2 cells (54), while
transformation of REF-52 cells requires a much larger por-
tion of T antigen and was affected by mutations located
throughout the coding region, including within the first 121
amino acids and as close to the carboxy terminus as residue
600 (44). Neither ras nor ElA acting alone transforms
REF-52 cells. Full transformation of REF-52 cells requires
collaboration of ras and ElA (15), suggesting that multiple
events must happen for REF-52 cells to become trans-
formed.
To further explore the mechanisms of transformation by
SV40 large T antigen, a large set of point, linker insertion,
and deletion mutants was assayed for transformation using
REF-52 and 1OT1/2 cells. Transformation of 1OT1/2 cells was
greatly reduced by mutation within the first exon of the gene
for large T antigen but was only modestly affected by
mutations affecting the plOSRb binding site. All mutants
which were defective for 1OT1/2 cell transformation were
defective for transformation of REF-52 cells. Mutants defec-
tive for binding to p1OSRb showed only a low ability to
transform REF-52 cells. In addition, there was a tight
correlation between the ability of mutants to transform
REF-52 cells and the ability of their T antigens to bind p53.
These results demonstrate that multiple regions of large T
antigen are required for full transformation of REF-52 cells.
These include sequences within the first exon of large T
antigen, the p105lb binding region, and the p53 binding
domain.
MATERIALS AND METHODS
Plasmids, cells, and tissue culture. REF-52 cells are an
established rat embryo fibroblast cell line (34). 1OT1/2 cells
are an established mouse fibroblast cell line (46). Both were
gifts from Jim Pipas (University of Pittsburgh, Pittsburgh,
Pa.) and were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with antibiotics and 10% fetal bo-
vine serum. This medium was supplemented with 400 ,ug of
G418 per ml when appropriate. CV-1 cells are a line of
African green monkey kidney cells (21); these cells were
cultured in DMEM supplemented with 10% newborn calf
serum (GIBCO/BRL). Wild-type and all mutant SV40 DNAs
were cloned into the EcoRI site of pUC18 in an orientation in
which the two BamHI sites were located close together.
pSV2neo contains a bacterial neomycin phosphotransferase
gene (53). Bacterial growth and transfection (36) and large-
scale plasmid purification by CsCI-ethidium bromide buoy-
ant density centrifugation (37) were done by standard tech-
niques.
SV40 mutants. The mutants used in these studies have
been described previously. Mutants in the 2400 series were
constructed by Tornow and Cole (58) and have deletions at
various DdeI sites within the early region of SV40. Some of
these encode nearly full-size T antigens lacking one to four
amino acids; due to a reading frame shift, others produce T
antigens truncated at sites near and downstream of the
deletion. Linker insertion mutants with a 12-bp linker (5'-
TCGCGATCGCGA-3') inserted at various sites within the
SV40 early region belong to the 2800 series (67). This linker
contains two sites for NruI and one for PvuI. Also included
in the 2800 series are some deletion mutants. Mutants
dlA2837, dlA2838, and dlA2839 were each prepared from
pairs of linker insertion mutants and carry deletions of the
SV40 DNA between the linker sites of the two parents (68).
Mutant dlA2837 lacks sequences encoding amino acids 168
to 346 and contains the 12-bp linker at the site of the
deletion. Mutants dlA2838 and dlA2839 lack sequences
encoding amino acids 409 to 520. Mutant dlA2838 contains
the 12-bp linker at the site of the deletion, while mutant
dlA2839 contains only half of the linker (a single NruI site).
Mutants are designated by their numbers. For insertion
mutants, the amino acid codon at the site of the insertion is
given in parentheses following the mutant number. For
deletion mutants, the amino acids missing from the T antigen
encoded by the mutant genome are listed in parentheses.
Two point mutants prepared in other laboratories (Kl [23]
and SVcT [27]) and one deletion mutant (MET128 [57]) were
also included in these studies. For point mutants, the amino
acid change created by the mutation is given in parentheses
following the mutant number.
Transformation assays. (i) Monolayer overgrowth assays.
REF-52 cells and 1OT1/2 cells were seeded into 100-mm
plates at a density of 105 cells per plate the day before
transfection. Each plate was transfected with 5 ,ug of wild-
type or mutant SV40 plasmid DNA and 10 ,ug of salmon
sperm carrier DNA, using the calcium phosphate method as
described by Wigler et al. (62). At 12 h posttransfection, the
cells were washed twice with TS (0.5 mM MgCI2, 1 mM
CaCl2, 25 mM Tris-Cl [pH 7.45], 130 mM NaCl, 5 mM KCI,
0.7 mM Na2HPO4) and allowed to recover for 24 h in DMEM
containing 10% fetal calf serum (FCS). The medium was
changed twice a week for 3 weeks. The cells were stained
with 0.5% methylene blue, and the formation of dense foci
on top of the monolayer of untransformed cells was scored
with a MasterScan interpretive densitometer. During the
scanning, a threshold was set just above the staining of the
control plate for each experiment. The densitometer scored
all of the foci above this threshold. Many plates were also
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scored by directly counting foci, and in all cases, virtually
identical results were obtained.
(ii) G418 selection. The G418 selection assays were similar
to the monolayer overgrowth assays except that each plate
of cells was also cotransfected with 0.5 ,ug of pSV2neo DNA
together with wild-type or mutant SV40 DNA and carrier
DNA. In some experiments, cells were split 1:4 48 h after
transfection. Cells were cultured in medium containing 400
,ug of G418 per ml, starting 3 days after transfection. The
cells were stained with methylene blue 2 to 3 weeks after
transfection, and dense colonies were scored with a Master-
Scan interpretive densitometer. In each assay, the DNA of
each mutant to be analyzed was transfected into two identi-
cal plates. In several assays using this ratio of T-antigen
plasmid to pSV2neo, multiple colonies were examined by
immunofluorescence, and all were found to express T anti-
gen.
Interaction of T antigens with p105Rb. Rb cRNA was
transcribed in vitro from a Stratagene pBluescript SK+
cloning vector containing the human Rb cDNA sequence
downstream from a T7 bacteriophage promoter by transcrip-
tion with T7 RNA polymerase. This plasmid was a kind gift
from Ed Harlow. p105Rb protein, labeled with [35S]methio-
nine, was synthesized in vitro by using a Promega (Madison,
Wis.) rabbit reticulocyte lysate system programmed with the
Rb cRNA. Rabbit reticulocyte lysate containing labeled Rb
protein was frozen at -20°C for 1 or 2 days before being used
in immunoprecipitation experiments.
Cultures of BALB/c 3T3 cells were cotransfected with
plasmids encoding wild-type or various mutant T antigens
and pSV2neo. Transfections were performed by the calcium
phosphate method as described above. Following recovery,
the cells were grown in DMEM-10% FCS-400 ,ug of Geneti-
cin (Sigma) per ml for 2 weeks to produce stably transformed
cell pools. CV-1 monkey kidney cells were calcium phos-
phate transfected with plasmid encoding mutant or wild-type
T antigen. At 16 h posttransfection, the cells were washed
twice with TS and allowed' to recover for 2 days in DMEM
containing 10% newborn calf serum. Stably transformed
BALB/c 3T3 cells and transiently transfected CV-1 cells
expressing wild-type or mutant T antigens were harvested
with lysis buffer containing 250 mM NaCl, 0.1% Nonidet
P-40, 50 mMN-2-hydroxyethylpiperazine-N'-2-ethanesulfon-
ic acid (HEPES pH 7.0), 1 mM phenylmethylsulfonyl fluo-
ride, 0.1 U of aprotinin (Sigma) per ml, and 10 p,g of
leupeptin (Sigma) per ml. This and subsequent steps were
performed at 4°C. The cellular debris was removed by
centrifugation for 15 min in a microcentrifuge.
The ability of wild-type and mutant T antigens to form
complexes with p105Rb was determined by slight modifica-
tion of the method described by Dyson et al. (13). Fifteen
microliters of the rabbit reticulocyte lysate containing la-
beled Rb protein was added to 1 ml of each mouse or
monkey cell lysate. Lysate mixtures were rocked gently for
1.5 h and then precleared for 30 min with 20 ,ul of protein
A-Sepharose beads (Pharmacia) which had been washed
three times with and resuspended in a volume of TBS-BSA
(25 mM Tris-Cl [pH 8.0], 120 mM NaCl, 10% bovine serum
albumin) equal to that of the packed Sepharose beads.
Following removal of the protein A-Sepharose beads, 10 [lI
of a mixture of mouse ascites fluids containing monoclonal
antibodies pAb901 and pAb9O2 was added and the lysate
mixtures were rocked gently for 1.5 h. These antibodies
recognize denaturation-resistant determinants located at the
carboxy and amino termini of T antigen, respectively (56).
Then 35 ptl of protein A-Sepharose beads in TBS-BSA was
added and rocking was continued for an additional hour,
after which the protein A-Sepharose beads and bound pro-
teins were pelleted, washed three times with cold lysis buffer
(without the protease inhibitors), and resuspended in sample
loading buffer (10% glycerol, 2% sodium dodecyl sulfate
[SDS], 0.2 mg of bromophenol blue per ml, 60 mM Tris-Cl
[pH 6.8], 0.05% [vol/vol] 3-mercaptoethanol). Samples were
heated at 70°C for 15 m, centrifuged in a microcentrifuge for
2 min, and placed on ice. Supernatants were loaded onto a
10% SDS-polyacrylamide gel. Labeled proteins were de-
tected by fluorography.
Comparison of the stabilities of wild-type and mutant T
antigens. Pools of REF-52 cells expressing wild-type or
mutant T antigens were selected by cotransfection of cells
with 0.5 pg of pSV2neo and 5.0 pug of a plasmid expressing
wild-type or mutant T antigen by the calcium phosphate
method. G418 (400 pug/ml) was added 48 h after transfection.
Colonies surviving selection were pooled approximately 2 to
3 weeks after transfection and used in subsequent experi-
ments. Cells in 60-mm dishes were incubated for 1 h in
DMEM lacking methionine and containing 2% dialyzed FCS
and were subsequently labeled with 100 puCi of [35S]methio-
nine (Translabel; Amersham) in a volume of 0.7 ml of the
same medium. After 1 h of labeling, the labeling medium was
removed, and cells were washed twice with TS and incu-
bated in 5 ml of DMEM containing 10% FCS. Cultures were
harvested 0, 2, 4, and 6 h later and processed for immuno-
precipitation as described previously (68).
RESULTS
The experiments described here were conducted to map
more precisely the regions of SV40 large T antigen required
for growth transformation of established cell lines and to
examine the correlations between these activities and the
other activities of large T antigen. We also report on the
ability of these mutant T antigens to interact with p105Rb. To
study transformation, we used two established cell lines,
mouse 1OT1/2 cells and rat REF-52 cells, because these lines
are widely used for studies of transformation by DNA tumor
viruses and because it has been shown that transformation of
1OT1/2 cells requires considerably less of T antigen (as little
as the N-terminal 121 amino acids [54]) than does transfor-
mation of REF-52 cells (which requires most of T antigen).
With both lines, it is easy to distinguish transformed foci
from normal cells.
Transformation of 1OT1/2 cells. Two different types of
assays were conducted. In the monolayer overgrowth assay,
cells were transfected with wild-type or various SV40 mu-
tant DNAs and then incubated with periodic changes of
media until foci formed. This assay tested for the ability of
transformed cells to overgrow a monolayer of normal cells.
In the other assay, cell cultures were cotransfected with
wild-type or various mutant DNAs and pSV2neo, which
confers resistance to the antibiotic G418. This procedure
permitted killing of those cells which did not take up DNA.
By using a high ratio of SV40 DNA to pSV2neo, most of the
cells which become resistant to G418 will also have taken up
SV40 DNA and expressed T antigen. The density of the
resultant clones of cells is an index of the level to which the
particular T antigen has transformed them. This second
assay is less stringent, and consequently, some mutants
showed a greater transformation potential by using this
assay. The data are shown in Table 1 and summarized in Fig.
1. Figure 2 shows representative plates of cells generated by
using each of these assays.
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TABLE 1. Transformation of 1OT1/2 cells by SV40 large-T-antigen mutants
Scoresb
Mutant Location of Dense focus assay G418 assaylesion'
Expt 1 Expt 2 Expt 3 Expt 4
Mock 1, 1 (0.02) 1, 0 (0.01) 0, 0 (0.00) 0, 0 (0.00)
pSV2neo No T antigen 1, 0 (0.02) 1, 0 (0.01)
1209 No T antigen 4, 2 (0.03) 5, 3 (0.19) 1, 0 (0.01)
Wild type 50, 63 (1.00) 93, 100 (1.00) 26, 16 (1.00) 30, 46 (1.00)
2801 in5 5, 5 (0.09) 5, 2 (0.04) 15, 14 (0.69) 20, 10 (0.39)
2831 dlS-35+in 0, 3 (0.02) 1, 3 (0.10) 0, 1 (0.01)
2803 in35 5, 1 (0.05) 1, 2 (0.02) 2, 0 (0.05) 3, 0 (0.04)
2441 d1106 79, 83 (0.84) 20, 15 (0.83) 25, 17 (0.55)
Kl Q107K 62, 69 (0.68)
SVcT K128Q 77, 66 (0.74) 14, 11 (0.60)
2420 1-128+6 60, 66 (0.65) 3, 5 (0.19) 20, 16 (0.47)
2411 d1143-146 98, 88 (0.96) 4, 6 (0.24) 31, 25 (0.74)
2815 in 168 60, 65 (1.11) 118, 105 (1.16) 18, 20 (0.90) 19, 15 (0.45)
2817 in219 68, 105 (1.53) 132, 159 (1.51) 11, 14 (0.60) 40, 25 (0.86)
2807 in302 52, 51 (0.91) 89, 74 (0.84) 14, 21 (0.83) 13, 12 (0.33)
2819 in346 60, 68 (1.13) 75, 72 (0.76) 14, 23 (0.88) 18, 11 (0.38)
2809 in409 36, 27 (0.56) 63, 39 (0.53) 19, 14 (0.79) 14, 10 (0.32)
2811 in424 35, 39 (0.65) 51, 67 (0.61) 10, 15 (0.60) 9, 11 (0.26)
2821 in460 65, 77 (1.26) 76, 70 (0.76) 13, 14 (0.64) 12, 11 (0.30)
2823 in464 65, 73 (1.22) 117, 102 (1.13) 22, 7 (0.69) 15, 17 (0.42)
2827 inS20 76, 116 (1.70) 122, 132 (1.32) 18, 17 (0.83) 22, 39 (0.80)
2828 inS20 72, 122 (1.72) 138, 135 (1.41) 15, 14 (0.69) 15, 26 (0.54)
2432 dlS07-510 114, 111 (1.17) 12, 21 (0.79) 36, 24 (0.79)
2416 1-508+3 37, 28 (0.34) 9, 7 (0.38) 3, 4 (0.09)
2433 d1587-589 46, 76 (0.63) 12, 5 (0.40) 11, 10 (0.28)
2829 in173 (small t) 2, 4 (0.03) 10, 11 (0.50) 18, 26 (0.58)
a The prefix "in" represents an insertion of a 12-bp linker, except for 2828, which has 6 bp inserted at codon 520. The suffix "+in" represents a linker inserted
at the site of the deletion. The prefix "dl" represents a deletion of the indicated amino acids. Point mutants are indicated by the wild-type single-letter amino acid
code, followed by its location and the mutant amino acid which replaces it. Frameshift deletion mutants are represented by the numbers indicating the amino acid
residues encoded by the mutants and followed by " +3", " +6", or " +26", indicating the numbers of amino acids from shifted reading frames as a result of reading
frame shift.
b Two numbers are the scores from two parallel plates in each experiment. Numbers in parentheses are the levels relative to that of wild-type SV40 DNA in
each experiment.
Results obtained in the monolayer overgrowth assay
agreed with the findings of others that only the amino-
terminal part of T antigen is required for transformation of
1OT1/2 cells (54). Mutant dlA2420(Aaal39-708) was able to
transform 1OT1/2 cells, though the efficiency of transforma-
tion was not as high as that of wild-type large T antigen. This
mutant encodes a T antigen consisting of the first 138 amino
acids of large T antigen plus 6 amino acids from the shifted
reading frame. The ability of T antigen to transform 1OT1/2
cells generally was not affected significantly by mutations
distal to amino acid 140 of large T antigen. However,
transformation efficiency was reduced with some mutants
[dlA2416(aa509-708) and dlA2433(aa587-589)] which produce
very unstable fragments of T antigen (58), even though their
T antigens contain much more of large T antigen than the
N-terminal 121 amino acids.
Some mutations within the first 35 amino acid residues
abolished the ability of T antigen to transform 1OT1/2 cells.
These mutants included inA2803(aa35) and dlA2831(aa5-35).
Mutations at the pl0SRb binding site [dl2441(aalO6) and
Kl(Q1O7K)] did not affect the transformation of 1OT1/2 cells
significantly. Kl has a point mutation converting Glu-107 to
Lys, and the mutant protein fails to bind plO"Rb (10).
d12441(aalO6) has a small in-frame deletion at the beginning
of the region involved in plo5Rb binding and showed very
little binding to p10 Rb (see Fig. 3). In addition, SVcT
(K127Q) (mutation at the nuclear localization signal) trans-
formed 1OT1/2 cells at wild-type efficiency.
Interestingly, 1OT1/2 cells transfected with in2801(aa5)
and in2829(small t-173) were able to form dense colonies in
G418 assays but failed to form dense foci efficiently in
monolayer overgrowth assays (Table 1 and Fig. 2). The fact
that 1OT1/2 cells transfected by either mutant which affected
small t antigen failed to form dense foci in the absence of
G418 selection suggests that small t antigen might play a role
in overcoming the contact growth inhibition by nontrans-
formed cells. While wild-type small t antigen has a half-life of
greater than 3 h, the half-life of the small t antigen encoded
by in2829(small t-173) was less than 30 min (49). We have not
examined the stability of the small t antigen encoded by
in2801(aa5).
We also note that some mutants whose lesions are very
close together [inA2827(aa520), inA2828(aa520), and dlA2432
(aa509)] routinely transformed more efficiently than did
wild-type SV40 in the monolayer overgrowth assay. The foci
produced in cultures transfected with these mutants were
detectable earlier than with wild-type SV40 and were always
larger and denser than wild-type foci (data not shown).
Transformation of REF-52 cells. The same two types of
assays used with 1OT1/2 cells were used to study the ability
of these mutants to transform REF-52 cells (Table 2 and Fig.
1 and 2). Several mutants were defective for REF-52 trans-
formation in both the monolayer overgrowth and G418
assays. These include the two mutants with lesions in the
first exon that were completely defective for transformation
of 1OT1/2 cells [inA2803(aa35) and dlA2831(aa5-35)] and
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FIG. 1. Comparison of abilities of mutants of T antigen to transform REF-52 and 10T1/2 cell lines and to bind to Rb. Locations of
mutations noted in the text are indicated above the cartoon of the protein. Arrows indicate linker insertion mutations and deletions of one
to five amino acids. The extent of larger deletions is indicated by a horizontal bar. Other functions of T antigen are indicated below the cartoon
of the protein. The abilities of mutants to transform C3H 1OT1/2 and REF-52 cells and to bind to Rb are indicated in the first three lines and
are summarized from Tables 1 and 2, respectively. Symbols for transformation by C3H 10T1/2 cells: +, greater than 30% of the wild-type
control (wt Tag) level; -, when less than 10% of the wild-type control level. Symbols for transformation by REF-52 cells: + + +, greater than
50% of the wild-type control level; + +, less than 50% but greater than 20% of the wild-type control level; +, less than 20% and greater than
1% of the wild-type control level; -, less than 1% of the wild-type control level. For Rb binding, an open circle represents no binding, a gray
circle represents weak but detectable binding, and a filled circle represents easily detectable binding. pol, polymerase; NLS, nuclear
localization signal; hf/hr, helper function/host range.
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truncated at amino (aal68-346) also transformed REF-52 cells. These results
(dlA2410). Mutant suggest that there are multiple discontinuous regions of large
at amino acid 626, T antigen involved in transformation; one or more regions
ndicating that the located within the first 138 residues are required along with
aired and dispens- portions of the sequences between residues 347 and 626.
is located between Since the T antigens encoded by many mutants with
only in the more lesions in the first exon of large T antigen produce very
Mutant dlA2837 unstable T antigens, the stabilities of the T antigens encoded
by inA2803(aa35) and dlA2831(aa5-35) were determined by
pulse-chase labeling of REF-52 cell pools expressing these T
2, ) i A- S03 antigens. The data are shown in Fig. 3. In this assay,
wild-type T antigen had a half-life of more than 10 h. It can
be seen that the T antigen encoded by inA2803(aa35) was
quite unstable, with a half-life of considerably less than 2 h.
The T antigen of inA2831(aa5-35), while not as stable as
wild-type T antigen, had a half-life of almost 4 h.
dlA2433(aa587-589) did not transform REF-52 cells, con-
firming that the hydrophobic region between amino acid
residues 570 and 590 is important for transformation of
REF-52 cells (44). Mutant dlA2433(aa587-589) encodes an
inA2809 K1 unstable protein. The instability of this mutant T antigen is
not sufficient to explain its total failure to transform REF-52
cells, however, since inA2807(aa302) T antigen, with an
insertion at the zinc finger region, is as unstable as
dlA2433(aa587-589) T antigen, and it transformed REF-52
cells to a substantial level although not as well as did wild-
type T antigen. Mutants in another region with the carboxyl
half of large T antigen, inA2809(aa409) and inA2811(aa424),
were also unable to transform REF-52 cells. Neither dlA2433
F-52 cells by mutant (aa587-589), inA2809(aa409), nor inA2811(aa424) T antigen is
O DNA alone (dense able to bind p53 (68). The T antigen of inA2811(aa424) is
(G418 assay) were relatively stable (67).
tively, of G418 (400 Mutations the p1O5Rb binding site affected the transfor-
of 10T1/2 cells (B) mation of REF-52 cells significantly. Kl protein, which does
40 mutants used are not bind plO5Rb (10), transformed REF-52 cells at about 2 to
is replaced with an 5% of the wild-type level. The level of transformation by
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TABLE 2. Transformation of REF-52 cells by SV40 large-T-antigen mutantsa
Scores
Mutant Location of Dense focus assay G418 assaylesion
Expt 1 Expt 2 Expt 3 Expt 4
Mock 0, 0 (0.00) 0, 0 (0.00) 0, 0 (0.00) 0, 0 (0.00)
pSV2neo No T antigen 2, 0 (0.06) 0, 0 (0.00)
1209 No T antigen 0, 0 (0.00) 0, 0 (0.00) 2, 1 (0.09)
Wild type 396, 387 (1.00) 343, 387 (1.00) 14, 21 (1.00) 85, 104 (1.00)
2801 inS 73, 69 (0.18) 25, 31 (0.08) 16, 15 (0.89) 58, 88 (0.77)
2831 dlS-35+in 0, 0 (0.00) 1, 0 (0.00) 1, 0 (0.03) 4, 3 (0.04)
2803 in35 0, 0 (0.00) 0, 0 (0.00) 4, 3 (0.20) 0, 1 (0.01)
2441 d1106 147, 96 (0.31) 62, 45 (0.15) 17, 11 (0.80) 63, 44 (0.57)
KI Q107K 26, 10 (0.05) 6, 7 (0.02)
SVcT K128Q 283, 246 (0.68) 101, 7 (0.15) 10, 12 (0.63)
MET128 dll-127 0, 1 (0.00)
2420 1-138+6 0, 0 (0.00) 0, 0 (0.00) 0, 3 (0.09)
2411 d1143-146 304, 327 (0.81) 246, 215 (0.63) 8, 6 (0.40)
2815 in168 364, 351 (0.91) 137, 136 (0.37) 12, 7 (0.54) 24, 19 (0.23)
2817 in219 721, 757 (1.89) 366, 380 (1.02) 27, 25 (1.49) 117, 113 (1.22)
2807 in302 28, 25 (0.07) 9, 7 (0.02) 8, 11 (0.54) 25, 9 (0.18)
2819 in346 235, 254 (0.62) 105, 114 (0.30) 14, 12 (0.74) 12, 29 (0.22)
2809 in409 0, 0 (0.00) 0, 0 (0.00) 1, 0 (0.03) 3, 3 (0.03)
2811 in424 0, 0 (0.00) 0, 0 (0.00) 0, 1 (0.03) 0, 3 (0.02)
2821 in460 213, 195 (0.52) 149, 134 (0.39) 16, 14 (0.86) 68, 51 (0.63)
2823 in464 151, 158 (0.39) 33, 49 (0.11) 13, 11 (0.69) 34, 33 (0.35)
2432 dl507-510 440, 441 (1.13) 376, 412 (1.08) 19, 17 (1.03)
2416 1-508+3 2, 1 (0.00) 0, 0 (0.00) 0, 0 (0.00)
2827 inS20 607, 622 (1.57) 448, 468 (1.25) 24, 19 (1.23) 168, 166 (1.77)
2828 inS20 682, 756 (1,84) 20, 17 (1.06) 103, 84 (0.99)
2433 d1587-589 0, 0 (0.00) 0, 0 (0.00) 1, 2 (0.09)
dlA2465 1-626+1 246, 190 (0.60)
2829 in173 (small t) 85, 141 (0.29) 42, 77 (0.16) 9, 7 (0.46) 14, 27 (0.22)
Mock 0, 0 (0.00) 0, 0 (0.00)
Wild type 79 (1.00) 80, 76 (1.00)
2837 d1168-346 9, 17 (0.16) 17, 30 (0.30)
2838 d1408-519+in 0, 0 (0.00) 0, 0 (0.00)
2839 d1408-519+6 0, 0 (0.00) 0, 0 (0.00)
a See footnotes to Table 1.
control and a number of transformation-negative mutants,
such as inA2803(aa35), dlA2831(aa5-35), inA2809(aa409),
and inA2811(aa424) (Fig. 1). Another mutant at the plO5 b
binding site, d12441(aalO6), transformed REF-52 cells 15 to
30% as well as did wild-type SV40 in the monolayer over-
growth assay and about 50 to 80% as well in the G418 assay.
SVcT(K127Q) transformed REF-52 cells at near wild-type
efficiency, indicating that the nuclear localization signal was
not required for transformation of REF-52 cells.
in2829(small t-173) transformed REF52 cells at a reduced
level in both monolayer overgrowth and G418 assays. There-
fore, small t antigen appeared to play a role in the transfor-
mation of REF-52 cells. Mutant inA2801(aa5) was very
defective for transformation of REF-52 cells in the mono-
layer overgrowth assay but transformed well in the G418
assay. This dependence on the assay used for transformation
of REF-52 cells by inA2801 was the same as that seen for
transformation of 1OT1/2 cells by this mutant. Whether this
result reflects the activity of the mutated large T, mutated
small t, or both antigens is not known. All mutants in regions
other than those discussed above transformed REF-52 cells
at or near the wild-type level.
p105Rbbinding by mutant large T antigens. To examine the
importance of binding to p105Rb for transformation, we
determined whether these mutant T antigens were able to
bind to p1o5Rb (Fig. 3). Cell extracts containing T antigens
were mixed with labeled p109lb, and the ability of an
anti-T-antigen monoclonal antibody (pAb901, pAb9O2,
pAblOl, or pAb416) to coprecipitate labeled Rb was exam-
ined. This approach has also been used by Dyson et al. (13)
to examine Rb interactions with T antigen, adenovirus ElA
proteins, and papillomavirus E7 proteins.
For these studies, we used stably transformed pools of
rodent cells expressing either wild-type or various mutant T
antigens (some from REF-52 cells and some from BALB/c
3T3 cells) as sources for wild-type or mutant T antigens. In
other experiments, we used transiently transfected monkey
kidney cells (CV-1). The wild type and some mutants were
analyzed by using T-antigen-containing extracts from multi-
ple sources, and no dependence of complex formation on the
source of T antigens was seen (data not shown).
In this assay, the plO5Rb produced by in vitro translation
contained polypeptides of many sizes (Fig. 4A, lane 1) which
result from protein synthesis initiation at internal AUGs
within the p105Rb-coding region (13). Since binding of T
antigen to plO5Rb requires plO9Rb sequences between amino
acids 393 and 772 (19), most of the smaller plO5Rb polypep-
tides synthesized in vitro were not able to bind T antigen
(Fig. 4A; compare lanes 1 and 4). The data showed that
plO5Rb was bound efficiently by large T antigen present in an
VOL. 66, 1992
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FIG. 3. Analysis of the stabilities of the T antigens encoded by
inA2803(aa35) and dlA2831(aa5-35). Cultures of REF-52 cells ex-
pressing mutant or wild-type T antigens (T Ag) were labeled with
[35S]methionine for 1 h and chased for 0, 2, 4, or 6 h as described in
Materials and Methods. T antigens were immunoprecipitated with
monoclonal antibodies pAb901 and pAb9O2 and separated by elec-
trophoresis. The gel was dried and autoradiographed.
extract of COS-1 cells, but none was bound when an extract
of uninfected CV-1 cells was used (Fig. 4A; compare lanes 4
and 3).
Most of the mutant T antigens were able to bind plO5Rb.
Some of the data are shown in Fig. 4, and all of the data are
summarized in Fig. 1. Two of the mutants examined,
Kl(Q107K) and d12441(aalO6), have lesions affecting the
binding site for plo5Rb. The only T antigen which showed no
detectable binding to plo5Rb in this assay was Kl(Q107K)
(Fig. 4A, lane 7; Fig. 4B, lane 5). With d12441(aalO6), very
weak binding only slightly above background was detected
on long exposure of the gel (Fig. 4B, lane 6). Since this
mutant encodes a stable T antigen and the concentration of
d12441 T antigen was comparable to that of wild-type T
antigen (Fig. 4C; compare lanes 2 and 6), we consider this
mutant to be defective for normal interactions with plO5Rb.
Mutant dlA2831(aa5-35), which was defective for transfor-
mation of both 1OT1/2 and REF-52 cells, nevertheless was
able to bind p105Rb (Fig. 4B, lane 4). Since dlA2831(aa5-35)
T antigen was relatively unstable, extracts contained only a
low level of this T antigen (Fig. 4C, lane 4), and only a small
amount of p105Rb was bound. We were unable to detect
p105Rb binding to inA2803(aa35) T antigen (Fig. 4B, lane 3),
since levels of this mutant T antigen were extremely low
(Fig. 4C, lane 3). However, we think it highly likely that this
T antigen binds p1095, since its T antigen contains all of the
sequences deleted in dlA2831(aa5-35) T antigen, which
bound plO5Rb. Thus, the mutants defective for normal
binding to p105Rb [(Kl(Q1O7K) and d12441(aalO6)] were
somewhat to substantially defective for transformation of
REF-52 cells (Table 2) but transformed 1OT1/2 cells effi-
ciently, though not as well as did wild-type SV40 (Table 1).
Together, these data suggest that the amino-terminal portion
of large T encodes two functions relevant for transformation:
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FIG. 4. T antigen-Rb binding. Shown are fluorographs of labeled
Rb protein immunoprecipitated with anti-T-antigen antibodies in the
absence or presence of wild-type and various mutant T antigens (A)
and (B) and immunoblot of T-antigen protein immunoprecipitated
from the other half of samples used in panel B (C). Lanes Rb lysate
and Lysate contain 1 ,ul of rabbit reticulocyte lysate from in vitro
translation reactions performed with and without, respectively,
human Rb cRNA. Immunoprecipitates from mixtures of Rb protein
and CV-1 cell extracts containing no T antigen were run in lanes
CV1. Immunoprecipitates from mixtures of Rb protein and COS cell
extracts containing wild-type T antigen were run in lanes COS. All
other lanes are marked according to the mutant T antigen expressed
by the CV-1 cells used to make each cellular extract. Molecular
weight markers are indicated in kilodaltons at the left of panels A
and B. In panel C, T antigen is marked by an arrow, and heavy- and
light-chain immunoglobulin proteins are marked by squares.
DISCUSSION
In the studies described here, established REF-52 cells
and 1OT1/2 cell lines were used to define more precisely the
domains of the SV40 early proteins involved in cellular
transformation. Both lines are already immortal, and immor-
talization of primary rodent cells is a critical step along the
path to their full transformation. We have recently described
the results of studies with SV40 mutants which showed that
the ability of mutants to immortalize primary mouse embryo
fibroblasts (MEFs) was tightly linked to the ability of mutant
T antigens to bind p53 (68).
These cell lines have different genetic requirements for
transformation and likely reflect different stages along the
pathway to complete malignant transformation. Fragments
J. VIROL.





FIG. 5. Summary of the functional domains required for trans-
formation by T antigen. Regions referred to in the text are marked
with brackets and are shaded. Pol, polymerase; N.L.S., nuclear
localization signal; Hr/Hf, host range/helper function.
from the N terminus of T antigen as short as 121 amino acids
are sufficient to transform 1OT1/2 cells, while transformation
of REF-52 cells requires sequences extending from the N
terminus of T antigen to beyond residue 600 (54). The results
of the studies presented here suggest that multiple regions of
large T antigen are important for transformation of REF-52
cells (Fig. 5). Region I is within the common region of large
T and small t antigens and has weak homology to conserved
region 1 of the adenovirus ElA proteins. Defects in both
large T and small t antigens could be involved in the
transformation phenotypes of mutants with lesions in region
I. Region II is the p105 b (and p107/120) binding site, which
extends from amino acids 105 to 114 (12, 14). The ability of
mutants affecting this site to transform have been studied in
several laboratories (6, 7, 23) with variable results. With a
few exceptions, mutants with single amino acid changes in
the p105 b binding site were only partially defective for
transformation.
Region III is defined by the mutations of inA2809(aa409)
and inA2811(aa424). These mutant T antigens are stable and
failed to bind p53. They were defective in transformation of
REF-52 cells and immortalization of primary MEF cells (68).
Several mutants with lesions between amino acids 460 and
520 retained the ability to transform REF-52 cells (Table 2),
immortalize primary MEFs, and bind p53 (68). Distal to this
area is a hydrophobic domain (amino acids 570 to 590).
Mutants with lesions in this region encode unstable T
antigens which failed to bind p53, to form oligomers larger
than dimers (65), to transform REF-52 cells, and to immor-
talize primary MEF cells. Mutants with these properties
include dlA2433(aa587-589) and 5080(P584L) (44). We sus-
pect that mutations affecting this hydrophobic domain alter
the conformation of much of the carboxyl half of large T
antigen and prevent it from interacting with p53. In a sense,
then, region III is bipartite since mutations at amino acids
409 and 424 as well as mutations within the hydrophobic
domain (amino acids 570 to 590) are defective for transfor-
mation, immortalization, and p53 binding, while mutations
between these two areas retain these properties. We hypoth-
esize that regions I, II, and III each likely specify interac-
tions between large T antigen and various cellular gene
products important for growth regulation.
Transformation by SV40 large T antigen. (i) 1OT1/2 cells.
Data about large T antigen presented here agree with previ-
ous observations that only the amino-terminal 121 amino
acids of large T antigen are sufficient for transformation of
1OT1/2 cells (54). dlA2420(aal39-708), which encodes 138
amino acids from the N terminus of T antigen, plus 6 amino
acids encoded by a shifted reading frame, was able to
transform 1OT1/2 cells. In fact, among the mutant SV40
DNAs examined, no mutations in the second exon of the
large-T-antigen-coding region abolished or significantly im-
paired the ability of T antigen to transform 1OT1/2 cells
(Table 1).
Mutants inA2803(aa35) and dlA2831(aa5-35) were com-
pletely defective for transformation of 1OT1/2 cells. This
region includes a sequence homologous to ElA conserved
region 1 (amino acids 9 to 20) (13). We have shown that
dlA2831(aa5-35) T antigen binds plOSRb (Fig. 4); because of
the very low levels of inA2803(aa35) T antigen, we could not
tell whether this mutant T antigen also binds Rb, but we
think it likely, since binding to plO5Rb was retained by
dlA2831(aa5-35), which has a much larger alteration within
the N-terminal portion of large T antigen. dlA1135 T antigen,
missing residues 17 to 27, also binds p10SRb and a related
107K/120K cellular protein (14). Therefore, some sequences
between 5 and 35 likely encode an activity essential for
transformation.
It is known that two separate activities of the adenovirus
ElA gene are required for cooperation with an activated ras
gene in the immortalization and transformation of primary
baby rat kidney cells (BRK) (64). Two mutants of adenovirus
ElA, one defective for p105 b binding and one defective for
p300 binding, can complement one another and cooperate
with an activated ras gene to transform BRK cells. Recently,
Yaciuk et al. (63) showed that mutants of SV40 defective for
Rb binding could complement mutants of ElA defective for
p300 binding for transformation of BRK cells. Similarly,
mutant dlA1135(aal7-27) was able to complement an ElA
mutant defective for plO5Rb binding. This finding suggests
that one possible role for T-antigen first-exon sequences is
interaction with p300. Given the functional and structural
relatedness of the transforming proteins from several pa-
povaviruses, adenoviruses, and papillomaviruses, it would
not be surprising if large T antigen interacts with the p300
protein or a related protein. Alternatively, one could also
argue that although this region (amino acids 5 to 35) is not
required for the binding of p105 b and p107/120, it might be
essential for inactivation of the normal functions of these
cellular proteins.
For in2801(aa5) and in2829(small t-173), two viable mu-
tants affecting small t antigen, different results were obtained
when two different protocols of transformation were used.
The two mutants failed to transform 1OT1/2 cells in the
monolayer overgrowth assay but transformed 1OT1/2 cells at
about 50% of the wild-type level in the G418 assay, suggest-
ing that small t antigen is playing some role in overcoming
contact inhibition by neighboring nontransformed cells.
Srinivasan et al. reported that d11137t, which encoded no
small t antigen, was able to transform 1OT1/2 cells (54). This
conclusion was based on the results of a G418 resistance
assay. Therefore, the role of small t antigen in transforma-
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and a combination of plasmids encoding various wild-type
and mutant large and small T antigens.
The transformation of 1OT1/2 cells by two mutants in the
p1o5Rb binding domain suggests that the intact p109lb bind-
ing site is not required for large T antigen to transform this
cell line. Mutant K1(Q107K) was unable to bind p1O5Rb (Fig.
4) (10) and is also unable to bind the p107/120 protein (14).
The data presented in Fig. 4 indicate that d12441(aa106) T
antigen may bind weakly to p105Rb, but the amount of
binding detected was only slightly above background. This
could mean that plO5Rb and p107/120 binding are not essen-
tial for the transformation of 1OT1/2 cells. We think it more
likely that the mutations in K1(Q107K) and d12441(106)
affect but do not totally prevent an interaction between T
antigen and p10 Rb or p107/120. This suggests caution in the
interpretation of results from plO5Rb binding experiments.
Although complexes between plO5Rb and various mutant T
antigens may not be detected by immunoprecipitation, inter-
actions may occur in vivo and be sufficiently stable to
suppress the activities of p109".
(ii) REF-52 cells. Transformation of REF-52 cells requires
the action of multiple oncogenes, e.g., cooperation of acti-
vated myc and ras oncogenes (17, 25). Those first-exon
mutants which were unable to transform 1OT1/2 cells
[inA2803(aa35) and dlA2831(aa5-35)] also lacked the ability
to transform REF-52 cells.
K1(Q107K) and d12441(aalO6) transformed REF-52 cells
at a substantially reduced level. This finding suggests that
binding of T antigen to p105", to p107, or to both plays a
role in transformation of REF-52 cells. The discussion above
about the relationship between the transformation of 1OT1/2
cells and binding of cellular proteins also applies to the
transformation of REF-52 cells.
Mutants with lesions in other portions of large T antigen,
inA2809(aa409), inA2811(aa424), and dlA2433(aa587-589),
lost the ability to transform REF-52 cells and retained the
ability to transform 1OT1/2 cells. All three mutations are
located within the sequences required for ATP-binding/
ATPase activity. None of the T antigens encoded by these
mutants could bind p53 (68). Other mutants with lesions in
this region [inA2821(aa460), inA2823(aa464), dlA2432(aa507-
510), inA2827(aa520), and inA2828(aa520)] were able to
transform REF-52 cells and retained the ability to bind p53.
Thus, there was a tight correlation between the ability of
mutants to bind p53 and their ability to transform REF-52
cells.
Two types of mutations might be expected to alter p53
interactions with large T antigen. One class are those which
alter residues directly involved in contact between T antigen
and p53. The other class are those whose mutations may lie
quite distant to residues contacted by p53 but which disrupt
the overall structure of the ATP-binding/ATPase domain.
We hypothesize that mutants inA2809(aa409) and inA2811
(aa424) fall into the first class and that mutant dlA2433
(587-589) falls into the second. Mutant dlA2433(aa587-589)
contains a deletion within a very hydrophobic region of large
T whose presence appears to correlate with the stability of
the protein and its overall structure. Analysis of the struc-
ture of dlA2433 T antigen by using a panel of monoclonal
antibodies indicates that dlA2433 T antigen does not react
with a substantial number of antibodies which recognize
conformationally sensitive sites within the C-terminal half of
the molecule (8). The importance of the hydrophobic region
(amino acids 570 to 590) for transformation was seen with
another mutant affecting this region, 5080(P584L) (55).
Lin and Simmons (31) have described mutants with point
mutations close to the position of the mutations of
inA2809(aa409) and inA2811(aa424), at residue 402. These
point mutants retained activity for SV40 DNA replication,
suggesting that the conformation of these amino acid 402
mutant T antigens is probably disrupted minimally. The
mutant T antigens, however, showed substantially reduced
interactions with rodent p53. Their ability to transform
rodent cells was not examined, but we predict that they will
show partial reduction in this activity.
Since the abilities of these mutant T antigens to immortal-
ize primary MEFs, to transform REF-52 cells, and to bind
p53 cosegregate, we suggest that all three properties reflect
the overall structure of the ATP-binding/ATPase domain of
large T. We note that those mutant T antigens which lose the
ability to immortalize, transform, or bind p53 in general also
lose the ability to react with several monoclonal antibodies
which recognize conformationally sensitive epitopes located
within the carboxyl half of large T; conversely, those which
retained these properties tend to react with most of these
antibodies. This finding suggests that the mechanism by
which the carboxyl half of large T antigen affects growth
regulation is through binding to p53 or related proteins. We
have not yet examined the ATP-binding or ATPase activity
of the mutant T antigens, but we showed previously that
ATPase activity could be uncoupled from transformation;
dlA2462(aa509) and dlA2432(aa507-510) both lack ATPase
activity (9) but retain full activity for immortalization (56)
and transformation (Table 2) and are able to bind p53.
inA2807(aa302) T antigen, with a linker insertion at the
zinc finger region (amino acid 302), is unstable (67) and
transformed REF-52 cells at a reduced but significant level.
This mutant also appeared to transform more efficiently in
the G418 assay than in the monolayer overgrowth assay,
though the differences were not always large. The zinc finger
motif has been shown to play a structural role. Mutants with
lesions in this domain encode unstable proteins which have
reduced DNA-binding and transforming capability (2, 33).
Although inA2807(aa302) T antigen retained the ability to
bind p53 (68) and p105Rb, its levels may be too low to permit
the mutant T antigen to sequester all of the p53 or p105Rb in
the cell.
One possible concern in interpretation of these data is the
instability of some of the mutant T antigens which showed
reduced transformation activity. The critical point here is to
understand whether failure to transform reflected reduced
levels of mutant T antigens with normal transformation
activities, altered activities of the mutant T antigens, or
both. For several reasons, we believe that the failure of
relatively unstable mutant T antigens to transform at wild-
type efficiency reflects qualitative defects of the mutant T
antigens and implicates the amino-terminal region of T
antigen in performing a specific function necessary for
transformation. First, mutant inA2807(aa302) retained con-
siderable transformation activity in 10T1/2 cells and trans-
formed REF-52 cells at a modest efficiency in the G418
assay. The T antigen of this mutant is very unstable,
indicating that relatively low levels of T antigen are sufficient
for transformation in some cell lines and with some assays.
Second, the ability of dlA1135(aal7-27) to complement an
ElA mutant defective for binding to p105Rb but not an ElA
mutant defective for binding to p300 (63) suggests that the
levels of dlA1135 T antigen in transfected rat cells are
sufficient for performing some of the transformation-related
activities of large T antigen; Marsilio et al. (40) showed that
dlA1135 T antigen was also very unstable. Third, Marsilio et
al. investigated the transformation activities of a number of
J. VIROL.
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mutants which each lack six amino acids in the large T/small
t common region (40). All of these mutants were defective
for transformation, but this could reflect the fact that all were
very unstable. Stabilizing one of the mutant T antigens by
insertion of six different amino acids at the site of the
deletion stabilized the mutant protein but failed to restore
transformation to normal or near normal levels, suggesting
that the large T/small t common region plays an active role in
transformation. However, it is not possible to determine
what role the substituted amino acids might by playing.
Additional evidence that the amino terminus of large T
antigen plays an essential role in transformation of REF-52
cells is the finding that mutant inA2831(aa5-35), which is
defective for transformation, encodes T antigen which is
considerably more stable than that of any other mutant with
a lesion in this region. Furthermore, REF-52 cells could be
transformed by complementation between mutant
inA2831(aa5-35) and an adenovirus ElA mutant defective for
binding to p105lb (66).
The results obtained in these studies are in general agree-
ment with results obtained by Srinivasan et al. (54) and by
others who used more limited sets of mutants than we did in
the studies reported here but are in disagreement with results
obtained by Sompayrac and Danna (52), who showed that a
fragment of T antigen comprising the N-terminal 147 amino
acids was sufficient to transform the rat Flll cell line and to
immortalize and transform rat embryo fibroblasts. They
suggest that when sufficient quantities of transformation-
active T antigen are found in an appropriate cellular com-
partment within the nucleus, transformation and immortal-
ization can occur, and that their N-terminal fragment of T
antigen is such a transformation-active form of T antigen.
Our studies do not address the question of whether or how
small fragments of T antigen could transform rat cells.
Possibly, such fragments are more effective than full-length
T antigens in inactivating some tumor suppressor proteins or
acquire new activities. Rather, our studies are directed at
understanding the requirements for transformation by wild-
type T antigen and derivatives of it which are of approxi-
mately wild-type size. However, we (Tables 1 and 2) and
others (22, 28, 41) have found that mutants of SV40 whose T
antigens are defective for nuclear localization were able to
transform established rat cell lines even though T antigens
were detected exclusively in the cytoplasm. The model
advanced by Sompayrac and Danna (52) does not account
for the behavior of these cytoplasmic T-antigen mutants,
since they do not accumulate to detectable levels within the
nuclear compartment.
How is transformation related to other properties of large T
antigen? A central goal of the studies described here and
other studies ongoing in our laboratory is to understand how
the various activities of SV40 large T antigen are related and
to gain insight into which of its properties are reflections of
the same biochemical activity. Figure 5 shows a diagram
illustrating the portions of large T antigen associated with its
various activities. Clearly, sequences critical for transforma-
tion of both 10T1/2 and REF-52 cell lines are located within
the N-terminal portion of the protein. This part of the large
T antigen is involved in DNA polymerase ot binding (11),
transcriptional activation of viral and cellular genes (69), and
binding to p105Rb and p107/120 (12, 14).
Mutants defective for transformation of both rodent cell
lines retained transactivation activity in monkey cells; con-
versely, mutants defective for transactivation in monkey
cells retained the ability to transform both rodent cell lines.
This is reminiscent of results obtained in studies on the
adenovirus ElA protein, which showed that the transcrip-
tional activation activity of ElA maps to the unique portion
of the 289-amino-acid 13S mRNA product of the ElA gene,
a region known to be completely dispensable for ElA
immortalization and transformation activities (42). Never-
theless, transactivation of some cellular genes may be im-
portant for transformation of rodent cells, and mutants
which failed to transform might not be able to transactivate
these genes.
The full transformation of cells, and the formation of
tumors in animals, is a multistep process. Each may result
from alterations in multiple proto-oncogenes, the loss of
multiple tumor suppressor genes, or some combination
thereof. Many studies indicate that expression of multiple
proto-oncogenes, activated by overexpression or mutation,
can immortalize and fully transform primary rodent embryo
fibroblasts (26, 48; for a review, see reference 20). The
multifunctional SV40 large T antigen, acting alone, is able to
both immortalize and transform primary cells. T antigen
forms complexes with two tumor suppressor proteins,
p105Rb and p53, and is thought to inactivate the growth
suppression properties of these proteins. That T antigen
might interact with still other tumor suppressor proteins is
possible. This suggests that the interactions between T
antigen and tumor suppressor proteins is likely to lie at the
heart of the mechanisms of immortalization and transforma-
tion by SV40 large T antigen. Furthermore, we suspect that
sequestration of tumor suppressor proteins by large T anti-
gen results in changes in patterns of cellular gene expression
critical for establishing the transformed phenotype.
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